Crescent Biopharma share price logo

Crescent Biopharma

NASDAQ: CBIO

Small Cap

$12.34

+0.50

(+4.22%)

as on

Crescent Biopharma Stock Performance

as on October 20, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.82
    $12.94
    downward going graph

    4.21%

    Downside

    4.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.72
    $27.41
    downward going graph

    29.34%

    Downside

    122.12%

    Upside

    downward going graph

Crescent Biopharma share price movements today

Previous Close
$11.84
Open
$12.42
Volume
360.0K
Market Cap
$439.8M
Day's Low - High
$11.82 - $12.94
52 Week Low - High
$8.72 - $27.41

Crescent Biopharma Historical Returns

1 Month Return
-29.9 %
3 Month Return
-19.73 %
1 Year Return
-5.58 %
3 Year Return
+ 96.84 %
5 Year Return
-78.72 %

Crescent Biopharma Stock Fundamentals & Key Indicators

Check Crescent Biopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$439.8M

EPS (TTM)

-6.72

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.56

Industry PE ratio

-7.03

PEG Ratio

-0.01

EBITDA

-162.9M

Revenue (TTM)

11.9M

Profit Margin

100.00%

Return On Equity TTM

-97.77%

Crescent Biopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Crescent Biopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$439.8M-78.72%-1.56100.00%0.00%
Neutral$87.0B-34.65%-29.64-12.57%0.00%
StrongBuy$126.7B169.53%28.8586.04%0.00%
Buy$81.4B43.22%19.0184.86%0.47%

Stock Returns calculator for Crescent Biopharma Stock including INR - Dollar returns

The Crescent Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Crescent Biopharma investment value today

Current value as on today

₹1,06,289

Returns

₹6,289

(+6.29%)

Returns from Crescent Biopharma Stock

-₹1,595 (-1.59%)

Dollar Impact

₹7,884 (+7.88%)

Analyst Recommendation on Crescent Biopharma Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Crescent Biopharma. Average target price of $30.6666666666667

Crescent Biopharma Share Price Target

Get share price movements and forecasts by analysts on Crescent Biopharma.

Current Price

$12.34

Analyzed by

3 Analysts

High

$36

0

Low

$28

Crescent Biopharma target price $0, a slight upside of 0% compared to current price of $12.34. According to 3 analysts rating.

Indian Investors' Interest in Crescent Biopharma Stock

Search interest for Crescent Biopharma Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Crescent Biopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
10
1
-
Gross Profit
-
-
-
-
-
-
-
10
1
-
Operating Income
-11
-10
-11
-17
-14
-21
-25
-91
-24
-26
EBITDA
-11
-10
-5
18
-14
-20
-24
-90
-23
-24
Interest Expense
-
-
-
0
1
1
-
-
-
-
Depreciation
0
0
0
35
-
0
0
0
0
0
Income Before Tax
-10
-10
-9
-17
-15
-21
-24
-90
-23
-24
Income Tax Expense
-
-
-
-
-
-
-
2
-
-
Net Income
-10
-10
-9
-17
-15
-21
-24
-92
-23
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
100.00%
0.00%

Crescent Biopharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
10
1
0
0
-
10
Gross Profit
0
0
0
10
1
0
0
-
10
Operating Income
-33
-51
-61
-51
-63
-47
-39
-49
-152
EBITDA
-33
-51
-56
-51
-63
-47
-39
-44
-149
Interest Expense
-
-
-
-
-
-
-
0
2
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-33
-48
-57
-51
-63
-46
-36
-48
-151
Income Tax Expense
-
3
-3
-
-
-
-
-
2
Net Income
-33
-48
-54
-51
-63
-46
-36
-48
-153
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%

Crescent Biopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-10
-10
-9
-7
-15
-21
-24
-92
-23
-24
Operating Cash Flow
-10
-8
-7
-3
-10
-16
-17
-26
-8
-19
Investing Cash Flow
0
0
-
0
-
0
0
-72
-8
1
Financing Cash Flow
0
0
-
-
-1
146
-1
178
-6
0
Change in Cash
-10
-8
-7
-3
-12
130
-19
79
-24
-17

Crescent Biopharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-48
-57
-51
-63
-46
-36
-37
-153
Operating Cash Flow
-29
-43
-51
-39
-57
-46
-34
-31
-71
Investing Cash Flow
0
0
0
0
0
0
0
0
-72
Financing Cash Flow
113
129
0
18
10
4
28
0
322
Change in Cash
83
85
-51
-21
-46
-42
-6
-31
178

Global Institutional Holdings in Crescent Biopharma

Check out the Institutions with significant holdings in Crescent Biopharma.

Funds
Holdings
Peter Harwin
7.40%
Vanguard
4.11%
iShares
3.00%
VANGUARD INDEX FUNDS
2.10%
Fidelity Mt. Vernon Street Trust
1.26%

Crescent Biopharma News & Key Events

  • img

    Today's Timeline - 15 October

    Fri, 02:18 AM

    -

    Crescent Biopharma reports progress in ASCEND trial, with initial data expected in Q1 2027 and plans for multiple ADC studies.

Insights on Crescent Biopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 743.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 164.7% return, outperforming this stock by 67.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, CBIO stock has moved down by -18.1%

About Crescent Biopharma

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
OrganisationCrescent Biopharma
Headquarters300 Fifth Avenue, Waltham, MA, 02451, US
IndustryBiotechnology
CEOJoshua T. Brumm

Key Management of Crescent Biopharma

Name

Title

Mr. Joshua T. Brumm

CEO & Director

Mr. Richard William Scalzo M.B.A.

Chief Financial Officer

Mr. Ryan Lynch

Senior VP of Finance, Treasurer & Chief Accounting Officer

Dr. Wenjie Cheng Ph.D.

Senior Vice President of Technical Operations

Ms. Barbara Bispham Hale J.D.

General Counsel & Corporate Secretary

Dr. Jonathan McNeill M.D.

President & COO

Dr. Ellie Im M.D.

Chief Medical Officer

Dr. Jan Pinkas Ph.D.

Chief Scientific Officer

Ms. Amy Reilly

Chief Communications Officer

Mr. Christopher Doughty

Chief Business Officer

FAQs

What is Crescent Biopharma share price today?

Crescent Biopharma share price today is $12.34 as on at the close of the market. Crescent Biopharma share today touched a day high of $12.94 and a low of $11.82.

What is the 52 week high and 52 week low for Crescent Biopharma share?

Crescent Biopharma share touched a 52 week high of $27.41 on and a 52 week low of $8.72 on . Crescent Biopharma stock price today i.e. is closed at $12.34,which is 54.98% down from its 52 week high and 41.51% up from its 52 week low.

What is Crescent Biopharma's market capitalisation today?

Crescent Biopharma market capitalisation is $0.00T as on .

How to invest in Crescent Biopharma Stock (CBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Crescent Biopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Crescent Biopharma Stock (CBIO) from India?

Indian investors can start investing in Crescent Biopharma (CBIO) shares with as little as ₹94.91500091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.15 in Crescent Biopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Crescent Biopharma share’s latest price of $12.34 as on October 20, 2026 at 1:29 am IST, you will get 0.8104 shares of Crescent Biopharma. Learn more about fractional shares .

What are the returns that Crescent Biopharma has given to Indian investors in the last 5 years?

Crescent Biopharma stock has given -78.72% share price returns and 26.42% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?